Neuroscientists have found the average person processes roughly 74 gigabytes of information every day.1 That is the equivalent of watching 16 movies, reading more than 200,000 words, or scrolling on TikTok for approximately 200 hours. In other words, we are inundated with information from every angle — social media, websites, […]
Tag: ORAL APPLIANCE THERAPY (OAT)
Panthera Dental Unveils BioMatch – A Single-Step Ordering and Appliance Design System for Dental Sleep Apnea Therapy
Panthera Dental, a global leader in CAD/CAM implant solutions and dental sleep medical devices, proudly announces the launch of its best-in-class BioMatch System, set to streamline the field of oral appliance therapy (OAT). The BioMatch System is designed to make ordering of a patient-matched appliance an effortless process, ease dental […]
The P4 Approach: What is it and How is it Being Used in Dental Sleep Medicine?
P4 medicine is an evolving approach to personalized medicine that involves four key elements of care: 1) predicting who will develop disease and comorbidities, 2) preventing rather than reacting to disease, 3) personalizing diagnosis and treatment, 4) having patients participate in their own care.1 This approach is gaining traction in […]
Slow Wave Oral Appliance FDA Cleared for OSA and Bruxism
The Slow Wave DS8™ oral appliance therapy (OAT), initially FDA-cleared for the prescription treatment of obstructive sleep apnea (OSA) in 2021 (K191320), has now been dually cleared by the FDA for the treatment of sleep bruxism (K240463). This makes the Slow Wave DS8, now marketed as BROSA™ when sold as […]
How Orofacial Myofunctional Therapy Can Aid in the Treatment of Sleep-Disordered Breathing
There has been an increasing number of studies looking at orofacial myofunctional therapy (OMT) as a promising adjunctive treatment for obstructive sleep apnea (OSA).1 OMT essentially helps the patient to retrain the muscles around the face, mouth, and tongue to establish correct oral rest posture and functioning of the oral […]
ProSomnus Announces Record Revenues as it Emerges from Reorganization
ProSomnus Sleep Technologies announced record revenues for the quarter that ended June 30, 2024, as it formally emerged from reorganization on August 5, 2024. Revenues for the second quarter totaled a record $9.1 million reflecting increasing orders for the Company’s precision intraoral medical devices. These quarterly results reflect a 22% […]
Panthera Dental Reaches New Milestone in Intellectual Property with Over 110 Patents
Panthera Dental is pleased to announce a remarkable milestone in its ongoing commitment to innovation and excellence: the company now holds over 110 patents across the dental, medical, and sleep appliance industries. This significant milestone follows their recent amicable settlement with ResMed SAS that resolves all ongoing patent infringement litigation […]
ProSomnus Files Chapter 11 Bankruptcy to Secure Financial Future
ProSomnus, Inc. announced it has initiated a voluntary restructuring process under Chapter 11 of the U.S. Bankruptcy Code to reorganize and strengthen its capital structure going forward, improve financial flexibility and better position the company for long-term success. In connection with this process, the Company has secured the support of […]
Panthera to Present Abstracts and Launch Inaugural “Panthera Sleep Research Grant” at AADSM & SLEEP 2024
Panthera Dental proudly announces that two distinct abstracts were accepted for poster presentations at the AADSM and AASM/SLEEP Annual Meetings. In addition, a funding opportunity through Panthera for investigator-initiated research proposals will be announced. The posters and the “Panthera Sleep Research Grant” reflect Panthera’s dedication to advancing dental sleep medicine […]
Swiss Startup Aesyra Raises $3M from Global Investors to Advance Innovations to Tackle Bruxism and OSA
Aesyra, a medical device company pioneering oral appliance technologies to improve sleep, announced it has raised $3 million in seed financing. The round was led by Supermoon Capital (USA), the world’s first fund focused on sleeptech, and deep tech investor Creadd Ventures (Switzerland) with participation from existing investor Zürcher Kantonalbank. […]













